cover
Contact Name
Mochamad Nashrullah
Contact Email
Nashrul.id@gmail.com
Phone
+6285136040851
Journal Mail Official
Nashrul.id@gmail.com
Editorial Address
Kavling Banar, Pilang, Sidoarjo, Jawa Timur
Location
Kab. sidoarjo,
Jawa timur
INDONESIA
Journal of Medical Genetics and Clinical Biology (JMGCB)
Published by Antis Publisher
ISSN : -     EISSN : 30321085     DOI : https://doi.org/10.61796/jmgcB
Core Subject : Health, Science,
Journal of Medical Genetics and Clinical Biology is a peer-reviewed forum for advances at the intersection of human genetics and clinical medicine. The journal welcomes original research, reviews, brief reports, and case reports that translate genomic discoveries into clinical utility—spanning diagnostic workflows, risk stratification, therapeutic decision-making, and implementation in real-world care. Areas of interest include Mendelian and complex disorders, cancer genetics, pharmacogenomics, biomarkers, clinical genomics (panel testing, WES/WGS), bioinformatics and data integration, as well as ethical and counseling considerations. By bridging molecular insights and bedside applications, the journal aims to support precision health and improve outcomes across diverse patient populations.
Articles 389 Documents
FORMULATION PERFORMANCE OF A MICROENCAPSULATED EUCALYPTUS–HERBAL SUGAR-FREE HARD CANDY AND ITS RELEVANCE TO PHARYNGEAL COMFORT Yassine Igoundaz; Spencer Moore; Youssef El Amrani
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 9 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i9.1925

Abstract

Objective: A hard candy remains in contact with the oral cavity for several minutes, so volatile retention, botanical taste and matrix stability all affect the finished product. We evaluated a sugar-free NVTIA hard candy containing monk fruit, Platycodon grandiflorus, lily bulb and low-glycyrrhizic-acid licorice extracts together with microencapsulated eucalyptus oil and menthol. Method: The optimized 2.50-g candy used an isomalt-maltitol-erythritol matrix. Botanical extracts were added at 108°C, followed by eucalyptus oil microcapsules and menthol at 92°C. The finished candy contained 2.35% moisture and had a mean unit mass of 2.50 g. In the 10-member experienced sensory panel, eight panelists rated eucalyptus-flavor uniformity as excellent, seven rated herbal bitterness as excellent (indicating slight bitterness), and eight rated overall acceptability as excellent. Results: Relative retention of 1,8-cineole was 82.1%. Replacing the microcapsule with liquid eucalyptus oil reduced 1,8-cineole retention to 64.5% and produced less uniform flavor. Removing lily preserved cineole retention but worsened bitterness and acceptability. Randomized human studies have reported reduced postoperative throat discomfort with topical licorice in several settings, including a licorice-lozenge study. Trials of a licorice-Platycodon combination for acute upper-respiratory-tract-infection sore throat found similar short-term improvement in active and placebo groups. Novelty: The formulation results define the sensory and volatile-retention performance of the complete candy and identify direct symptom and sensory endpoints for formulation-specific pharyngeal-comfort studies.
SOD-RICH MELON POLYSACCHARIDE–PROTEIN COMPLEX MODULATES MELANOGENESIS-RELATED RESPONSES: EXPERIMENTAL EVIDENCE AND TRANSLATIONAL CONTEXT FOR ORAL SKIN BRIGHTENING Bougrain Mouad; Aina Sofea; Sri Wahyuni
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 9 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i9.1926

Abstract

Objective: The BCLC® SOD-Rich Melon Endogenous Polysaccharide–Protein Complex was examined in two skin-relevant cell models. Method: In α-MSH-stimulated B16-F10 cells, melanin content fell from the model reference of 100% to 92.5%, 84.8%, and 76.3% at 25, 50, and 100 μg/mL, respectively. Tyrosinase activity decreased to 94.6%, 88.4%, and 80.2%, while cell viability remained above 93% at the highest dose. In H₂O₂-stressed HaCaT keratinocytes, the same extract reduced intracellular ROS and also showed strong in-vitro radical-scavenging activity. The material contains SOD, endogenous soluble polysaccharides, and protein in a low-reducing-sugar matrix without an exogenous prolamin or lipid coating. Results: Human studies of other SOD-rich melon or melon-containing oral products have reported changes in luminosity, L* value, ITA°, melanin-related indices, and broader skin-quality measures. Novelty: The cell results identify a redox–melanogenesis pattern that can be tested prospectively with objective skin-color endpoints in a formulation-specific BCLC® study.
ORAL-HEALTH RELEVANCE OF A POLYOL-DOMINANT SUGAR-FREE HARD CANDY MATRIX: FORMULATION ARCHITECTURE AND HUMAN CLINICAL EVIDENCE Yassine Igoundaz; Jacob Turner; Caleb Whitmore
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 9 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i9.1928

Abstract

Objective: Sugar-free confectionery can reduce exposure to fermentable sugars, but oral-health relevance depends on the specific polyol matrix, product acidity and pattern of use. We characterized the matrix architecture of an NVTIA herbal hard candy containing 75.685 parts isomalt, 20.000 parts maltitol syrup on a dry-matter basis and 2.500 parts erythritol per 100 parts formulation, together accounting for 98.185% of the dry formulation. Method: The candy also contained low levels of citric acid and sodium citrate, botanical extracts, eucalyptus oil microcapsule powder and menthol. Formulation data were integrated with primary human and in situ studies of erythritol, maltitol and isomalt. Results: A three-year randomized trial in 485 schoolchildren found that erythritol candy was associated with fewer dentin-caries lesions at selected follow-ups and longer times to lesion development or progression than xylitol or sorbitol controls; companion analyses reported lower plaque weight, lower plaque organic-acid levels and reduced mutans streptococci with erythritol. Maltitol randomized studies show favorable effects on plaque acidogenicity, cariogenic bacteria and selected caries-risk variables. Short isomalt exposures have also shown favorable effects on enamel de-/remineralization balance in an in situ study. At the same time, primary studies of sugar-free acidic lozenges and confections demonstrate that low cariogenicity and low erosive potential are distinct product properties. Novelty: Accordingly, the polyol-dominant matrix provides a strong scientific basis for reduced cariogenic substrate exposure, while direct measurement of finished-product pH, titratable acidity, plaque-pH response and enamel-surface effects can further define its complete oral-health profile. The present analysis establishes a formulation-specific framework for oral-health evaluation while retaining the complete product as the principal unit of interpretation.
A STABILIZED SOD-RICH MELON POLYSACCHARIDE–PROTEIN COMPLEX PRESERVES ANTIOXIDANT ACTIVITY AND SUPPORTS OXIDATIVE-STRESS HOMEOSTASIS Bougrain Mouad; Sipho Dlamini; Nur Aisyah
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 9 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i9.1929

Abstract

Objective: Plant-derived superoxide dismutase (SOD) is of interest for nutritional antioxidant use, but oral delivery places the enzyme under several forms of stress, including gastric acidity, heat, moisture, and the composition of the surrounding powder matrix. Method: We characterized the BCLC® SOD-Rich Melon Complex, a low-reducing-sugar endogenous polysaccharide–protein preparation in which native Cucumis melo soluble polysaccharides are retained with SOD-containing protein fractions without an exogenous prolamin or lipid-soluble coating. Low-temperature, low-oxygen extraction followed by ultrafiltration/diafiltration, controlled pH–ionic-strength complexation, and low-temperature drying yielded optimized extracts containing 34,280–43,620 U/g SOD, 3.7–4.5% reducing sugars, and water activity of 0.29–0.34. Results: After 60 min at pH 1.2 and 37°C, SOD retention was 41.7–47.8%, compared with 16.9–38.2% in comparator preparations. After 30 days at 40°C/75% RH, 66.5–72.6% of activity remained. DPPH scavenging was 57.8–63.7%, ABTS scavenging was 65.7–71.6%, and ORAC values were 2,064–2,416 μmol TE/g. Human studies using other SOD-rich melon preparations have also reported changes in oxidative-stress-related outcomes. Novelty: The formulation data define a practical basis for human evaluation of this endogenous melon polysaccharide–protein stabilization approach.
ANTIMICROBIAL SUSCEPTIBILITY AND BIOFILM FORMATION IN CLINICAL ISOLATES OF P. AERUGINOSA FROM PATIENTS AT MOSUL HOSPITAL Ahmed Thabit Jabbar
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 8 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i8.1872

Abstract

Objective: The study was designed to investigate the occurrence, distribution of samples, and antibiotic resistance and biofilm forming potential of P. aeruginosa. Method: This descriptive cross-sectional study, including 225 clinical samples, spanned from December 2018 to June 2019 and isolated P. aeruginosa were identified by traditional biochemical tests and confirmed by the VITEK 2 compact system. Antimicrobial susceptibility testing was done by Kirby-Bauer disk diffusion method according to CLSI 2025. Biofilm production was measured by Tissue Culture Plate method and Isolates were graded as weak, moderate and strong biofilm producers on the Basis of optical density. Results: A total of 12.8% (29/225) prevailed the recovery of P. aeruginosa and wound specimen displayed the maximum rate (22%, χ² = 18.55, p = 0.005). Antimicrobial susceptibility results showed that imipenem and levofloxacin were the most active (62.1% each), while gentamicin was found to be the least resisted (96.6%). Multidrug-resistant (MDR) and pandrug-resistant (PDR) patterns were found in 58.6% and 20.7% of the isolates. All isolates were shown to produce biofilm, with 17% weak, 48% moderate and 34% strong biofilm producers. Nevertheless, there was no significant correlation between the degree of biofilm formation and the profile of resistance to antimicrobials (p 0.05). Novelty: Although biofilm production was not directly associated with resistance profiles, its implication in chronic infections highlights the importance of developing specific strategies to interfere with biofilm production in clinical applications.
EVALUATION OF EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL) IN RENAL CALCULI MANAGEMENT: A RETROSPECTIVE-SIMULATED MULTI-CENTER STUDY IN BAGHDAD, IRAQ Ameer Najy Obeed; Ali Jaafar Obaid; Ali S. Hammadi; Jaafar Hamid Jaafar Al-Waeli; Hanadi Tahseen Muslem; Ali Kumait Hamad
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 10 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i10.1943

Abstract

Objective: This study aims to evaluate the clinical efficacy, success rates, and associated complication profiles of ESWL for renal calculi across specialized urology centers in Baghdad, Iraq, utilizing simulated multi-center clinical data. Method: A retrospective-simulated cohort of 300 patients (180 males, 120 females; mean age 43.2 ± 11.5 years) treated with modern electromagnetic and piezoelectric lithotripters over a 12-month period was analyzed. Stone parameters, stone-free rates (SFR) at 3 months post-procedure, session requirements, and complication indices were statistically evaluated. Results: The overall stone-free rate (SFR) at 3 months was 78.3%. For calculi smaller than 1.5 cm, the success rate reached 85.4%, compared to 57.1% for stones equal to or exceeding 1.5 cm. A secondary session was required in 21.7% of cases, predominantly driven by stone density (greater than 1000 HU) and increased stone burden. Minor complications, primarily transient gross hematuria and self-limiting renal colic, were observed in 11.7% of patients, with zero major Clavien-Dindo grade III-V complications. Novelty: ESWL demonstrates exceptional safety and efficacy in Baghdad's urological centers for small-to-moderate renal calculi. Strict patient selection based on stone size, skin-to-stone distance, and composition significantly enhances therapeutic outcomes.
STUDY OF KEY IMMUNOLOGICAL AND HEPATIC INDICATORS IN PATIENTS WITH HEPATITIS B VIRUS ATTENDING AND ADMITTED TO MERJAN TEACHING HOSPITAL IN BABYLON PROVINCE Ameer Najy Obeed; Thara Habeeb Khudir; Zahraa Hamza Merza; Howadia Nazzal Hussein; Dhai Mohammed Rahman; Ali Kumait
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 9 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i9.1945

Abstract

Objective: This cross-sectional study aimed to evaluate key hepatic cellular markers and systemic inflammatory responses among HBV-infected patients attending outpatient clinics and admitted to inpatient wards at Merjan Teaching Hospital in Babylon Province, Iraq. Method: Serum levels of liver transaminases—alanine aminotransferase (ALT) and aspartate aminotransferase (AST)—were quantitatively measured alongside pro-inflammatory cytokines, specifically Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α), using Enzyme-Linked Immunosorbent Assay (ELISA) techniques, and compared against healthy controls. Results: Statistically significant elevations (p ≤ 0.01 for liver enzymes; p ≤ 0.001 for cytokines) were observed in HBV patients compared to the control group. Novelty: These findings demonstrate that continuous immune-mediated hepatocyte destruction and cytokine dysregulation drive the pathogenesis of HBV, underlining the clinical relevance of incorporating cytokine profiling alongside standard liver function tests for improved diagnostic and prognostic monitoring.
ANTAGONISTIC POTENTIAL OF THE WEISSELLA CIBARIA STRAIN AGAINST OPPORTUNISTIC PATHOGENIC BACTERIA AND PHYTOPATHOGENIC FUNGI Guzal Jumaniyazovna Kutlieva; Bahora Ismailovna Turaeva; Tulkin Erkinovich Shonakhunov; Khulkar Fozil qizi Kamolova
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 10 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i10.1946

Abstract

Objective: The antimicrobial activity of the Weissella cibaria culture against opportunistic bacteria and phytopathogenic fungi was studied. Method: Antimicrobial activity was assessed using the drop-spot method. Antifungal activity was evaluated using the agar block method. Results: High activity was demonstrated against Proteus morganii 399 with a growth inhibition zone of 39  mm, Proteus mirabilis - 42 мм, against Candida albicans 40 mm and Pseudomonas aeruginosa 32 mm. Antagonistic activity against phytopathogenic fungi was noted for Verticillium dahliae – 40 mm, Aspergillus flavus – 32 mm, Alternaria alternata – 30 mm, Aspergillus oryzae – 28 mm, and Aspergillus oryzae – 25 mm. Novelty: These results show that the strain can suppress bacteria, yeasts and filamentous fungi, which makes it a promising candidate for biocontrol agents, food preservation and probiotic development.
TARGETED PHOTO-INDUCED THERMAL ANNIHILATION OF DRUG-RESISTANT BACTERIAL PATHOGENS UTILIZING ENGINEERED METALLIC PLASMONIC NANOARCHITECTURES Dr. Ameer Najy Obeed; Ali. S. Hammadi; Kareem Obayes Handool
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 7 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i7.1949

Abstract

Objective: This work assesses the biophysical capability of bio-synthesized silver nanoparticles (AgNPs) and gold nanorods (AuNRs) functionalized with target-specific antibodies to selectively exterminate Staphylococcus aureus and Pseudomonas aeruginosa under near-infrared (NIR) laser stimulation (Sperling & Parak, 2008; Uusitalo et al., 2025). Method: Metallic nanostructures were fabricated through eco-friendly green chemistry procedures and comprehensively characterized via UV-Vis spectrophotometry, transmission electron microscopy (TEM), and atomic force microscopy (AFM) (Alivisatos, 1996; Kelly et al., 2003). Bacterial cultures were subjected to an 808 nm optical laser field across diverse power densities (0.5–2.0 W/cm²), followed by real-time tracking of localized micro-hyperthermia, cell envelope degradation, and bacterial survival kinetics (Indhu et al., 2023; Link & El-Sayed, 1999). Results: Synthesized AuNRs exhibited an intense, localized surface plasmon resonance (LSPR) band centered at 808 nm, achieving a localized temperature elevation (ΔT) of 24.5 °C within a 5-minute irradiation window at 50 µg/mL (Huang et al., 2006). This light-to-heat energy transduction triggered irreversible protein coagulation, lipid membrane oxidation, and an overall 99.8% mortality rate in resistant isolates without incurring cytotoxicity to non-target mammalian cells (Vankayala & Hwang, 2018; Zhou et al., 2022). Novelty: Plasmonic-driven photothermal therapy represents an exceptionally effective, rapid, and biophysically distinct paradigm capable of bypassing conventional bacterial resistance mechanisms.

Filter by Year

2024 2026


Filter By Issues
All Issue Vol. 3 No. 10 (2026): Journal of Medical Genetics and Clinical Biology Vol. 3 No. 9 (2026): Journal of Medical Genetics and Clinical Biology Vol. 3 No. 8 (2026): Journal of Medical Genetics and Clinical Biology Vol. 3 No. 7 (2026): Journal of Medical Genetics and Clinical Biology Vol. 3 No. 1 (2026): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 12 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 11 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 10 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 9 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 8 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 7 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 6 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 5 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 4 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 3 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 2 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 1 (2025): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 12 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 11 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 10 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 9 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 8 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 7 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 6 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 5 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 4 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 3 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 2 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 1 (2024): Journal of Medical Genetics and Clinical Biology More Issue